JP Morgan Chase’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-272,526
| Closed | -$114K | – | 7514 |
|
|
2022
Q4 | $114K | Buy |
272,526
+8,327
| +3% | +$4.48K | ﹤0.01% | 5305 |
|
|
2022
Q3 | $206K | Buy |
264,199
+33,259
| +14% | +$35K | ﹤0.01% | 4942 |
|
|
2022
Q2 | $295K | Sell |
230,940
-215,790
| -48% | -$284K | ﹤0.01% | 4871 |
|
|
2022
Q1 | $630K | Sell |
446,730
-67,035
| -13% | -$143K | ﹤0.01% | 4554 |
|
|
2021
Q4 | $1.4M | Buy |
513,765
+45,637
| +10% | +$168K | ﹤0.01% | 4131 |
|
|
2021
Q3 | $2.23M | Sell |
468,128
-116,044
| -20% | -$848K | ﹤0.01% | 3701 |
|
|
2021
Q2 | $4.71M | Sell |
584,172
-149,032
| -20% | -$1.24M | ﹤0.01% | 3103 |
|
|
2021
Q1 | $5.88M | Sell |
733,204
-7,959
| -1% | -$74.1K | ﹤0.01% | 2830 |
|
|
2020
Q4 | $6.63M | Sell |
741,163
-248,543
| -25% | -$2.07M | ﹤0.01% | 2566 |
|
|
2020
Q3 | $7.32M | Sell |
989,706
-78,775
| -7% | -$546K | ﹤0.01% | 2277 |
|
|
2020
Q2 | $6.81M | Buy |
1,068,481
+552,137
| +107% | +$3.69M | ﹤0.01% | 2215 |
|
|
2020
Q1 | $3.84M | Buy |
516,344
+387,673
| +301% | +$3M | ﹤0.01% | 2484 |
|
|
2019
Q4 | $1.16M | Sell |
128,671
-278,872
| -68% | -$2.34M | ﹤0.01% | 3747 |
|
|
2019
Q3 | $3.06M | Buy |
407,543
+15,379
| +4% | +$86.3K | ﹤0.01% | 3108 |
|
|
2019
Q2 | $1.9M | Sell |
392,164
-83,096
| -17% | -$542K | ﹤0.01% | 3418 |
|
|
2019
Q1 | $3.98M | Sell |
475,260
-494,622
| -51% | -$3.56M | ﹤0.01% | 2778 |
|
|
2018
Q4 | $4.17M | Buy |
969,882
+166,875
| +21% | +$1.48M | ﹤0.01% | 2726 |
|
|
2018
Q3 | $11.7M | Sell |
803,007
-205,532
| -20% | -$3.41M | ﹤0.01% | 2071 |
|
|
2018
Q2 | $18.8M | Sell |
1,008,539
-146,925
| -13% | -$2.66M | ﹤0.01% | 1646 |
|
|
2018
Q1 | $20.1M | Sell |
1,155,464
-962,738
| -45% | -$17M | ﹤0.01% | 1505 |
|
|
2017
Q4 | $35.7M | Buy |
2,118,202
+535,088
| +34% | +$8.71M | 0.01% | 1161 |
|
|
2017
Q3 | $24.6M | Sell |
1,583,114
-300,320
| -16% | -$4.29M | 0.01% | 1371 |
|
|
2017
Q2 | $24.9M | Buy |
1,883,434
+725,303
| +63% | +$9.53M | 0.01% | 1313 |
|
|
2017
Q1 | $13.8M | Buy |
1,158,131
+573,083
| +98% | +$6.87M | ﹤0.01% | 1723 |
|
|
2016
Q4 | $7.63M | Sell |
585,048
-267,645
| -31% | -$3.08M | ﹤0.01% | 2121 |
|
|
2016
Q3 | $9.53M | Buy |
852,693
+90,980
| +12% | +$1.09M | ﹤0.01% | 1829 |
|
|
2016
Q2 | $9.24M | Buy |
761,713
+559,308
| +276% | +$6.59M | ﹤0.01% | 1891 |
|
|
2016
Q1 | $2.67M | Buy |
+202,405
| New | +$2.87M | ﹤0.01% | 2545 |
|
|
2015
Q3 | – | Sell |
-18,800
| Closed | -$406K | – | 4138 |
|
|
2015
Q2 | $406K | Sell |
18,800
-30,365
| -62% | -$643K | ﹤0.01% | 3629 |
|
|
2015
Q1 | $954K | Buy |
49,165
+9,283
| +23% | +$161K | ﹤0.01% | 3247 |
|
|
2014
Q4 | $668K | Buy |
+39,882
| New | +$605K | ﹤0.01% | 3551 |
|
|
2014
Q3 | – | Sell |
-21,692
| Closed | -$398K | – | 4287 |
|
|
2014
Q2 | $398K | Buy |
21,692
+1,864
| +9% | +$31.6K | ﹤0.01% | 3194 |
|
|
2014
Q1 | $379K | Sell |
19,828
-184,964
| -90% | -$3.8M | ﹤0.01% | 3224 |
|
|
2013
Q4 | $4.75M | Sell |
204,792
-24,884
| -11% | -$515K | ﹤0.01% | 2206 |
|
|
2013
Q3 | $3.97M | Buy |
229,676
+52,827
| +30% | +$839K | ﹤0.01% | 2341 |
|
|
2013
Q2 | $2.54M | Buy |
+176,849
| New | +$2.45M | ﹤0.01% | 2623 |
|
Other funds holding IVC
PCMI
IIM
AA
WFA
HNB
HCM
JP Morgan Chase's IVC Position: Q1 2023 in Review
JP Morgan Chase sold out of Invacare Corporation (IVC) in Q1 2023, closing a stake of 272,526 shares — an estimated $114K sold.
JP Morgan Chase first reported a position in IVC in Q2 2013 and held it in 36 quarters. The position peaked at $35.7M in Q4 2017. 10 funds tracked by Wall St. Rank hold IVC as of Q1 2023.
- JP Morgan Chase reported no remaining Invacare Corporation position as of Q1 2023 after selling out during the quarter.
- JP Morgan Chase sold 272,526 Invacare Corporation shares in Q1 2023, an estimated $114K.
- JP Morgan Chase first reported a position in Invacare Corporation in Q2 2013 and held it in 36 quarters.
- JP Morgan Chase's Invacare Corporation position peaked at $35.7M in Q4 2017.
- 10 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2023.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.